Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lifshitz Law PLLC Announces Investigations of Stride, Inc. (NYSE: LRN), Firefly Aerospace Inc. (NASDAQ: FLY), Fiserv, Inc. (NASDAQ: FISV), and Inspire Medical Systems, Inc. (NYSE: INSP)

accessnewswire.com
LRN Investigation announced into possible securities law violations due to allegations of materially false and misleading statements, including inflating enrollment, cutting staffing, ignoring compliance, suppressing whistleblowers, and losing enrollments. FLY Investigation announced into possible securities law violations due to allegations of overstating demand and growth prospects for Spacecraft Solutions and overstating operational readiness of the Alpha rocket program. FISV Investigation announced into possible securities law violations due to allegations of misleading statements regarding guidance revisions, with the company admitting assumptions were difficult to achieve and a lack of comprehensive review led to deprioritizing short-term initiatives. INSP Investigation announced into possible securities law violations due to allegations of materially false and misleading statements regarding significantly weaker market demand for Inspire V and insufficient steps for a successful launch.

NEW YORK CITY, NY / ACCESS Newswire / April 14, 2026 / Lifshitz Law Firm

Stride, Inc. (NYSE:LRN)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Stride represented to investors that "[t]hese products and services, spanning curriculum, systems, instruction, and support services are designed to help learners of all ages reach their full potential through inspired teaching and personalized learning;" and (ii) unbeknownst to investors Stride was: (a) inflating enrollment numbers by retaining "ghost students"; (b) cutting staffing costs by assigning teachers' caseloads far beyond the required statutory limits; (c) ignoring compliance requirements, including background checks and licensure laws for its employees, and ignoring federally mandated special education services to students; (d) suppressing whistleblowers who documented financial directives from Stride's leadership to delay hiring and deny services to preserve profit margins; and (e) losing existing and potential enrollments.

If you are an LRN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Firefly Aerospace Inc. (NASDAQ:FLY)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) Firefly had overstated the demand and growth prospects for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the Offering Documents and the Company's public statements throughout the Relevant Period were materially false and/or misleading and failed to state information required to be stated therein.

If you are an FLY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Fiserv, Inc. (NASDAQ:FISV)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) In July 2025, Fiserv revised its 2025 guidance, including lowering its organic revenue growth guidance. Fiserv told the market that its guidance changes were based on a review, termed a "re-underwrit[ing]," of the Company's new initiatives and products. The Company told investors that although certain of those initiatives and projects were delayed, they were fundamentally sound; (ii) as Fiserv would later admit in October 2025, the Company's 2025 guidance disclosed in July 2025 was based on "assumptions . . . which would have been objectively difficult to achieve even with the right investment and strong execution."; and (iii) Fiserv's "re-underwrit[ing]" of its initiatives and products turned out to have focused only on its largest offerings and was not comprehensive. After Fiserv actually conducted a comprehensive review during the third quarter, it concluded that its initiatives and products "place[d] too much emphasis on pursuing in-quarter results as opposed to building longterm relationships." Thus, Fiserv announced in October that it "made the decision to deprioritize the short-term revenue and expense initiatives," which would negatively impact the Company's short-term "growth and profitability."

If you are an FISV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Inspire Medical Systems, Inc. (NYSE:INSP)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) actual market demand for Inspire V was significantly weaker than represented; (ii) the Company had not taken the necessary steps to ensure a successful launch of Inspire V; and (iii) as a result, the Company's statements regarding demand for Inspire V and the Company's readiness for launch were materially false and misleading at all relevant times.

If you are an INSP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email:[email protected]

SOURCE: Lifshitz Law Firm